Coagulation disorders are commonly encountered in the ICU. Many conditions including sepsis, malignancy, trauma, vasculitic disorders, and obstetrical accidents may give rise to a coagulopathy. In addition, patients may have medical conditions which predispose them to developing a coagulopathy, e.g., patients with liver disease, renal failure, lupus, leukemia, etc. Sepsis, however, is the single most common factor leading to a coagulopathy and DIC. DIC has been reported in about 10–20% of patients with gram-negative bacteremia and 70% of patients with septic shock. In patients with sepsis, DIC appears to be an important independent predictor of ARDS, multiple organ dysfunction syndrome, and death (see Chapter 10).
Disseminate Intravascular Coagulation Multiple Organ Dysfunction Syndrome Coagulation Test Amniotic Fluid Embolism Overt Disseminate Intravascular Coagulation
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Taylor FB Jr, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327–1330.PubMedGoogle Scholar
Gando S. Acute coagulopathy of trauma shock and coagulopathy of trauma: A Rebuttal. You are now going down the wrong path. J Trauma. 2009;67:381–383.PubMedCrossRefGoogle Scholar
Khan H, Belsher J, Yilmaz M, et al. Fresh frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest. 2007;131:1308–1314.PubMedCrossRefGoogle Scholar
Watson GA, Sperry JL, Rosengart MR, et al. Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma. 2009;67:221–230.PubMedCrossRefGoogle Scholar
Sarani B, Dunkman WJ, Dean L, et al. Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med. 2008;36:1114–1118.PubMedCrossRefGoogle Scholar
De Backer D, Vandekerckhove B, Stanworth S, et al. Guidelines for the use of fresh frozen plasma. Acta Clinica Belgica 2008;63:381–390.PubMedGoogle Scholar
Dzik WH. The James Blundell Award Lecture 2006: transfusion and the treatment of haemorrhage: past, present and future. Transfus Med. 2007;17:367–374.PubMedCrossRefGoogle Scholar
Segal JB, Dzik WH. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion. 2005;45:1413–1425.PubMedCrossRefGoogle Scholar
Holland LL, Brooks JP. Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am J Clin Path. 2006;126:133–139.PubMedCrossRefGoogle Scholar
Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion. 2006;46:1279–1285.PubMedCrossRefGoogle Scholar
Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:160S–198S.PubMedCrossRefGoogle Scholar
Dezee KJ, Shimeall WT, Douglas KM, et al. Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis. Arch Intern Med. 2006;166:391–397.PubMedGoogle Scholar
Crowther MA, Ageno W, Garcia D, et al. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med. 2009;150:293–300.PubMedGoogle Scholar